Cogent Biosciences, Inc.

COGT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001622229

SEC filings (opens in a new tab)

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Cogent Biosciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of COGT: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	177	2	186	+11
Shares	121.7M	313.1K	133.5M	+12.1M (+10.0%)
Value	$949.5M	$2.44M	$799.6M	−$147.4M (−15.6%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Cogent Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to COGT in Q1 2025
Institution	Shares	Value	% of portfolio
Vestal Point Capital, LP	3,000,000	$18.0M	1.28%
Exome Asset Management LLC	621,678	$3.72M	3.34%
Sphera Funds Management Ltd.	335,024	$2.01M	0.49%
SummitTX Capital, L.P.	297,128	$1.78M	0.08%
Rosalind Advisors, Inc.	248,285	$1.49M	0.72%
Nuveen, LLC	233,852	$1.40M	0.00%
Knott David M Jr	213,302	$1.28M	0.60%
Bank of Montreal	205,030	$1.23M	0.00%
Prelude Capital Management, LLC	169,449	$1.01M	0.10%
Graham Capital Management, L.P.	73,993	$443.2K	0.01%
Voloridge Investment Management, LLC	66,930	$400.9K	0.00%
Dark Forest Capital Management LP	28,982	$173.6K	0.01%
Gsa Capital Partners LLP	25,248	$151.0K	0.01%
CIBC World Markets Corp	20,361	$122.0K	0.00%
Virtus Investment Advisers, Inc.	19,687	$117.9K	0.03%
LPL Financial LLC	19,003	$113.8K	0.00%
Ensign Peak Advisors, Inc	18,825	$112.8K	0.00%
Ieq Capital, LLC	16,792	$100.6K	0.00%
Creative Planning	10,494	$62.9K	0.00%
Crowley Wealth Management, Inc.	1,700	$10.2K	0.01%
Group One Trading, L.P.	660	$3.95K	0.00%
Boston Private Wealth LLC	539	$3.23K	0.00%
Skopos Labs, Inc.	316	$1.89K	0.00%
True Wealth Design, LLC	277	$1.66K	0.00%
J.Safra Asset Management Corp	266	$1.59K	0.00%
US Bancorp	226	$1.35K	0.00%
Parkside Financial Bank & Trust	65	$389	0.00%
CoreCap Advisors, LLC	62	$371	0.00%
Stephens Consulting, LLC	60	$360	0.00%
Larson Financial Group LLC	16	$96	0.00%
Garde Capital, Inc.	10	$60	0.00%

Sold out (20)

Institutions that held Cogent Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of COGT in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Adage Capital Partners GP, L.L.C.	4,300,000	$33.5M
Silverarc Capital Management, LLC	921,137	$7.18M
Crestline Management, LP	369,763	$2.88M
Avidity Partners Management LP	287,104	$2.24M
Squarepoint Ops LLC	128,799	$1.00M
Caption Management, LLC	112,100	$874.4K
ExodusPoint Capital Management, LP	67,381	$526.0K
HRT Financial LP	57,056	$445.0K
Cinctive Capital Management LP	40,643	$317.0K
Omers Administration Corp	30,300	$236.3K
Wolverine Trading, LLC	22,325	$172.1K
Optimize Financial Inc	20,186	$157.5K
Two Sigma Advisers, LP	18,915	$147.5K
Panagora Asset Management Inc	14,712	$114.8K
Atom Investors LP	14,277	$111.4K
Virtus ETF Advisers LLC	8,524	$66.5K
R Squared Ltd	910	$7.10K
Private Wealth Management Group, LLC	284	$2.22K
Smartleaf Asset Management LLC	273	$2.10K
Allworth Financial LP	33	$271

Not filed for Q1 2025 yet (2)

Institutions that held Cogent Biosciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding COGT in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	313,099	$2.44M
Cassady Schiller Wealth Management, LLC	31	$242